Sponsor content
39 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZEPZELCA lurbinectedin 2 mg powder for solution for infusion vial.
-
Jun-2026Prescription medicine evaluationActive ingredient: navepegritide.
-
Prescription medicine registrationActive ingredients: lurbinectedin.
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYTROFA lonapegsomatropin 6.3 mg powder and solvent for solution for injection dual chamber glass cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYTROFA lonapegsomatropin 3 mg powder and solvent for solution for injection dual chamber glass cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYTROFA lonapegsomatropin 3.6 mg powder and solvent for solution for injection dual chamber glass cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYTROFA lonapegsomatropin 13.3 mg powder and solvent for solution for injection dual chamber glass cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYTROFA lonapegsomatropin 7.6 mg powder and solvent for solution for injection dual chamber glass cartridge.